logo
Select company
Select metric
$ -3.81MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
37
Sector
41
Industry
45
History
48
$ 2.95Close
$ 1.1 - $ 13.42 52-Week Range
Ticker Information

Ticker

TRAW

Company Name

TRAWS PHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TRAWS PHARMA INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TRAW - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ -3.81M
3/31/2025$ -453K
12/31/2024$ 517K
9/30/2024$ -19.83M
6/30/2024$ -12.84M
3/31/2024$ -17.83M
12/31/2023$ -17.94M
9/30/2023$ -17.37M
6/30/2023$ -16.8M
3/31/2023$ -16.55M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TRAWS PHARMA INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ 19.38M.
  • Over the past 5 years, TRAWS PHARMA INC's average CF - Chg. Cash has been $ -1.5M.
  • The median CF - Chg. Cash for TRAWS PHARMA INC during this period was $ -3.75M
  • TRAWS PHARMA INC reached its highest CF - Chg. Cash over the past 5 years at $ 36.05M.
  • The lowest CF - Chg. Cash recorded by TRAWS PHARMA INC in the same timeframe $ -19.83M

TRAWS PHARMA INC's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
CYCN : CYCLERION THERAPEUTICS INC $ -1.58MLGVN : LONGEVERON INC $ -2.04MBOLT : BOLT BIOTHERAPEUTICS INC $ 3.4MLYRA : LYRA THERAPEUTICS INC $ -2.12MXBIO : XENETIC BIOSCIENCES INC $ -2.52MBRTX : BIORESTORATIVE THERAPIES INC $ -697KTXMD : THERAPEUTICSMD INC $ 837KAPRE : APREA THERAPEUTICS INC $ -12.17MLPCN : LIPOCINE INC $ 490.61KTNON : TENON MEDICAL INC $ 5.88M

Similar metrics to CF - Chg. Cash:

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

TRAW - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -19.83M

Minimum

Sep 30, 2024

$ 36.05M

Maximum

Dec 31, 2021

$ -1.5M

Average

$ -3.75M

Median

CF - Chg. Cash Benchmark Analysis

 The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.12M with a standard deviation of $ 45.01M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -137M
max$ 137.58M
average$ 1.12M
median$ 104K
std$ 45.01M